Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

·L'utilisation de particules pseudo-virales (VLPs) pour l'administration de protéines antigéniques est une approche attractive. Le but de ce projet est de concevoir des VLPs fluorescentes à base de protéines structurelles gag virales couplées à la enhanced Green Fluorescent Protein (eGFP). La visualisation des VLPs permettra l'étude de leur comportement, l'évaluation de la capture cellulaire in vitro et de leur devenir in vivo.Dans ce contexte, les plasmides codant les protéines gag des virus de l'immunodéficience humaine (HIV) et de la leucémie murine (MLV) fusionnées à la eGFP, ont été clonés. Les VLPs fluorescentes, enveloppées avec la glycoprotéine G du virus de la stomatite vésiculaire (VSV-G) ou non ont ensuite été produites dans des cellules embryonnaires rénales humaines (293T) puis caractérisées qualitativement et quantitativement.La capture cellulaire des VLPs fluorescentes par des macrophages (J774) a été évaluée avec succès par cytométrie de flux . Cependant, l'évaluation in vivo des VLPs fluorescentes a été compromise par l'autofluorescence émise par la peau des souris.L'ensemble des résultats obtenus suggère que les VLPs fluorescentes produites in vitro sont captées efficacement par les cellules et pourront permettre des études in vivo après optimisation de leur visualisation. Using virus-like particles (VLPs) to deliver antigenics proteins is an attractive method. The aim of this project is to design fluorescent VLPs using a gag-enhanced Green Fluorescent Protein (eGFP) fusion constructs to study their caracteristics and to evaluate cellular uptake in vitro and in vivo outcome. In this context, plasmids fused eGFP, based on gag proteins from human immunodeficiency virus (HIV) and murine leukemia virus (MLV) were cloned. The, fluorescents VLPs with glycoprotein G from vesicular stomatitis virus (VSV-G) or naked fluorescents VLPs were produced in human embryonnary kidney cells (293T) and caracterized qualitatively and quantitatively. VLPs uptake in macrophages (J774) was evaluated with success by flow cytometry. Yet, aveluation of fluorescents VLPs uptake in vivo was compromised by emitted autofluoresence from skin mice. Taken together, these results suggest cellular uptake of fluorescents VLPs produced in vitro is effective and may allow in vivo studies after optimizing their visualization.

Plasmids --- Genetic Vectors --- Vaccination

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Gene Therapy for Viral Infections provides a comprehensive review of the broader field of nucleic acid and its use in treating viral infections. The text bridges the gap between basic science and important clinical applications of the technology, providing a systematic, integrated review of the advances in nucleic acid-based antiviral drugs and the potential advantages of new technologies over current treatment options. Coverage begins with the fundamentals, exploring varying topics, including harnessing RNAi to silence viral gene expression, antiviral gene editing, viral gene therapy vec.--

Gene therapy. --- Genetic vectors.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Virology --- Viruses --- Genetics, Microbial --- Molecular Biology --- methods --- Genetics, Microbial. --- Molecular Biology. --- Biochemical Genetics --- Biology, Molecular --- Genetics, Biochemical --- Genetics, Molecular --- Molecular Genetics --- Biochemical Genetic --- Genetic, Biochemical --- Genetic, Molecular --- Molecular Genetic --- Microbial Genetics --- Genetic, Microbial --- Microbial Genetic --- Virus Physiological Phenomena --- Bacterial Physiological Phenomena --- Genome, Microbial --- Animal Viruses --- Zoophaginae --- Animal Virus --- Virus --- Virus, Animal --- Viruses, Animal --- Genetic Vectors --- Microbiology --- Genetic Phenomena --- Viruses. --- methods. --- Virology - methods

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Today, we are far less likely to die from infection than at any other time in history, but still we worry about epidemics, the menace of antibiotic resistance and modern 'plagues' like Ebola. In this timely new book, eminent bacteriologist Hugh Pennington explores why these fears remain and why they are unfounded. He reports on outright victories (such as smallpox), battles where the enemy is on its last stand (polio), surprise attacks from vegetarian bats (Ebola, SARS) and demented cows (BSE). Qualified optimism, he argues, is the message for the future but the battles will go on forever. -- Provided by publisher.

Bacteria. --- Viruses. --- Communicable diseases --- World health. --- Epidemics --- 616.98 --- bacteriën --- virussen --- Infectieziekten --- #SBIB:316.334.2A15 --- #SBIB:316.334.2A500 --- Global health --- International health --- Public health --- Medical geography --- Contagion and contagious diseases --- Contagious diseases --- Infectious diseases --- Microbial diseases in human beings --- Zymotic diseases --- Diseases --- Infection --- Medical microbiology --- Quarantine --- Biosecurity --- Genetic vectors --- Microorganisms --- Mobile genetic elements --- Extrachromosomal DNA --- Germs --- Microbes --- Prokaryotes --- Prevention. --- Treatment. --- History. --- Specifieke infectieziekten Infecties toe te schrijven aan bepaalde organismen. Bacteriële en virale infecties --- Arbeidssociologische onderzoeksmethoden en technieken --- Organisatiesociologie: algemeen --- International cooperation --- BACTERIA --- COMMUNICABLE DISEASES--PREVENTION --- Bacteria --- Viruses --- World health --- Prevention --- Treatment --- History --- Communicable diseases - Prevention --- Communicable diseases - Treatment --- Epidemics - History